Skip to main content
Log in

Recalls of EpiPen auto-injectors in Denmark, Ireland and Australia

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Therapeutic Goods Administration. EpiPen 300 microgram adrenaline injection syringe auto-injector: recall - potential failure to activate or need to apply increased force to activate. Internet Document : 22 Mar 2017. Available from: URL: https://www.tga.gov.au/alert/epipen-300-microgram-adrenaline-injection-syringe-auto-injector.

  2. Danish Medicines Agency. Withdrawal of a batch of EpiPen 300 micrograms. Internet Document : 17 Mar 2017. Available from: URL: http://laegemiddelstyrelsen.dk/en/news/withdrawal-of-a-batch-of-epipen-300-micrograms/.

  3. Health Products Regulatory Authority. Recall of one lot of Epipen 300mcg to patient level in Ireland. Internet Document : 21 Mar 2017. Available from: URL: http://www.hpra.ie/homepage/medicines/safety-notices/item?t=/recall-of-one-lot-of-epipen-300mcg-to-patient-level-in-ireland&id=60cc0726-9782-6eee-9b55-ff00008c97d0.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Recalls of EpiPen auto-injectors in Denmark, Ireland and Australia. Reactions Weekly 1645, 6 (2017). https://doi.org/10.1007/s40278-017-28088-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-28088-x

Navigation